Brandon E. Kremer
- Molecular Biology top 10%
- Cell Biology top 5%
- Oncology
- Surgery
- Hematology top 10%
- Co-authors
- Ian G. MacaraLaura AdangTimothy HaysteadSanjay SinhaGary K. OwensFrédéric DandréDa‐Zhi WangMark H. Hoofnagle
- Topics
- Multiple Myeloma Research and Treatments (18 papers)Protein Degradation and Inhibitors (17 papers)Peptidase Inhibition and Analysis (5 papers)
- Cited by
- AgingCell BiologyMolecular Biology
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Brandon E. Kremer
33 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 91
- Molecular Biology 833
- Cell Biology 231
- Oncology 192
- Surgery 131
- Hematology 120
Countries citing papers authored by Brandon E. Kremer
This map shows the geographic impact of Brandon E. Kremer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon E. Kremer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon E. Kremer more than expected).
Fields of papers citing papers by Brandon E. Kremer
This network shows the impact of papers produced by Brandon E. Kremer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon E. Kremer. The network helps show where Brandon E. Kremer may publish in the future.
Co-authorship network of co-authors of Brandon E. Kremer
This figure shows the co-authorship network connecting the top 25 collaborators of Brandon E. Kremer. A scholar is included among the top collaborators of Brandon E. Kremer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandon E. Kremer. Brandon E. Kremer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 3 | |
| 5 | 9 | |
| 6 | 0 | |
| 7 | 17 | |
| 8 | Dreamm-4: evaluating safety and clinical activity of belantamab mafodotin (belamaf) in combination with pembrolizumab in patients with relapsed/refractory multiple myeloma (rrmm) | 1 |
| 9 | 5 | |
| 10 | 8 | |
| 11 | 23 | |
| 12 | 2 | |
| 13 | 8 | |
| 14 | 35 | |
| 15 | 181 | |
| 16 | 160 | |
| 17 | 139 | |
| 18 | 20 | |
| 19 | 7 | |
| 20 | 7 |
About Brandon E. Kremer
Brandon E. Kremer is a scholar working on Hematology, Aging and Molecular Biology, having authored 37 papers that have together received 1.2k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (18 papers), Protein Degradation and Inhibitors (17 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Aging (32 citations), Cell Biology (231 citations) and Molecular Biology (833 citations). Brandon E. Kremer has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Ian G. Macara, Laura Adang, Timothy Haystead, Sanjay Sinha, Gary K. Owens, Frédéric Dandré, Da‐Zhi Wang, Mark H. Hoofnagle, Brian R. Wamhoff and Eric N. Olson. Their work appears in journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.